FA
ZBH icon

Friess Associates’s Zimmer Biomet ZBH Stock Holding History

Friess Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-131,325
Closed -$19.1M – 144
2019
Q4 		$19.1M Hold
131,325
– – 1.33% 39
2019
Q3 		$17.5M Buy
+131,325
New +$17M 1.35% 39
2018
Q1 		– Sell
-161,082
Closed -$18.9M – 122
2017
Q4 		$18.9M Buy
+161,082
New +$18.2M 1.56% 20

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Friess Associates's ZBH Position: Q1 2020 in Review

Friess Associates sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 131,325 shares — an estimated $19.1M sold.

Friess Associates first reported a position in ZBH in Q4 2017 and held it in 3 quarters. The position peaked at $19.1M in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Friess Associates reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Friess Associates sold 131,325 Zimmer Biomet shares in Q1 2020, an estimated $19.1M.
  • Friess Associates first reported a position in Zimmer Biomet in Q4 2017 and held it in 3 quarters.
  • Friess Associates's Zimmer Biomet position peaked at $19.1M in Q4 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.